Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care

Adam F. Binder, Nathan R. Handley, Lindsay Wilde, Neil Palmisiano, Ana Maria Lopez

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

In late January 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) was reported as an outbreak in Wuhan, China. Within 2 months it became a global pandemic. Patients with cancer are at highest risk for both contracting and suffering complications of its resultant disease, Coronavirus 19 (COVID-19). Healthcare systems across the world had to adapt quickly to mitigate this risk, while continuing to provide potentially lifesaving treatment to patients. Bringing care to the home through the use of telehealth, home based chemotherapy, and remote patient monitoring technologies can help minimize risk to the patient and healthcare workers without sacrificing quality of care delivered. These care models provide the right treatment, to the right patient, at the right time, in the right place. Whether these patient-centered models of care will continue to be embraced by key stakeholders after the pandemic remains uncertain.

Original languageEnglish (US)
Article number1183
JournalFrontiers in Oncology
Volume10
DOIs
StatePublished - Jun 26 2020
Externally publishedYes

Keywords

  • care at home
  • digital technology
  • healthcare innovation
  • patient centered care
  • telehealth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Treating Hematologic Malignancies During a Pandemic: Utilizing Telehealth and Digital Technology to Optimize Care'. Together they form a unique fingerprint.

Cite this